guide sporotricose
11 pág.

guide sporotricose

DisciplinaInfectologia1.652 materiais7.421 seguidores
Pré-visualização8 páginas
KD, Moore FM, Geiger GE, Stemper ME. Zoonotic transmission
of sporotrichosis: case report and review. Clin Infect Dis 1993; 16:
4. Conti Diaz IA. Epidemiology of sporotrichosis in Latin America. My-
copathologia 1989; 108:113\u20136.
5. Dixon DM, Salkin IF, Duncan RA, et al. Isolation and characterization
of Sporothrix schenckii from clinical and environmental sources asso-
ciated with the largest US epidemic of sporotrichosis. J Clin Microbiol
1991; 29:1106\u201313.
6. Hajjeh R, McDonnell S, Reef S, et al. Outbreak of sporotrichosis among
tree nursery workers. J Infect Dis 1997; 176:499\u2013504.
7. Dooley DP, Bostic PS, Beckius ML. Spook house sporotrichosis: a point-
source outbreak of sporotrichosis associated with hay bale props in a
Halloween haunted-house. Arch Intern Med 1997; 157:1885\u20137.
8. Lurie HI. Five unusual cases of sporotrichosis from South Africa show-
ing lesions in muscles, bones, and viscera. Br J Surg 1963; 50:585\u201391.
9. Kauffman CA. Old and new therapies for sporotrichosis. Clin Infect
Dis 1995; 21:981\u20135.
10. Barros MB, Schubach Ade O, do Valle AC, et al. Cat-transmitted spo-
rotrichosis epidemic in Rio de Janeiro, Brazil: description of a series
of cases. Clin Infect Dis 2004; 38:529\u201335.
11. Kwon-Chung KJ. Comparison of isolates of Sporothrix schenckii ob-
tained from fixed cutaneous lesions with isolates from other types of
lesions. J Infect Dis 1979; 139:424\u201331.
12. Pappas PG, Tellez I, Deep AE, Nolasco D, Holgado W, Bustamante B.
Sporotrichosis in Peru: description of an area of hyperendemicity. Clin
Infect Dis 2000; 30:65\u201370.
13. Bayer AS, Scott VJ, Guze LB. Fungal arthritis. III. Sporotrichal arthritis.
Semin Arthritis Rheum 1979; 9:66\u201374.
14. Crout JE, Brewer NS, Tompkins RB. Sporotrichosis arthritis: clinical
features in seven patients. Ann Intern Med 1977; 86:294\u20137.
15. Howell SJ, Toohey JS. Sporotrichal arthritis in south central Kansas.
Clin Orthop Relat Res 1998; 346:207\u201314.
16. Stratton CW, Lichtenstein KA, Lowenstein SR, Phelps DB, Reller LB.
Granulomatous tenosynovitis and carpal tunnel syndrome caused by
Sporothrix schenckii. Am J Med 1981; 71:161\u20134.
17. Schwartz DA. Sporothrix tenosynovitis\u2014differential diagnosis of gran-
ulomatous inflammatory disease of the joints. J Rheumatol 1989; 16:
18. Sharkey-Mathis PK, Kauffman CA, Graybill JR, et al. Treatment of
sporotrichosis with itraconazole. NIAID Mycoses Study Group. Am J
Med 1993; 95:279\u201385.
19. Pluss JL, Opal SM. Pulmonary sporotrichosis: review of treatment and
outcome. Medicine (Baltimore) 1986; 65:143\u201353.
20. Kauffman CA, Pappas PG, McKinsey DS, et al. Treatment of lympho-
cutaneous and visceral sporotrichosis with fluconazole. Clin Infect Dis
1996; 22:46\u201350.
21. Khabie N, Boyce TG, Roberts GD, Thompson DM. Laryngeal spo-
rotrichosis causing stridor in a young child. Int J Pediatr Otorhino-
laryngol 2003; 67:819\u201323.
22. Henry LR, Danaher PJ, Boseley ME. Laryngeal sporotrichosis mim-
icking merkel cell carcinoma recurrence. Otolaryngol Head Neck Surg
2005; 132:336\u20138.
23. Torrealba JR, Carvalho J, Corliss R, England D. Laryngeal granulo-
matous infection by Sporothrix schenckii. Otolaryngol Head Neck Surg
2005; 132:339\u201340.
24. Gullberg RM, Quintanilla A, Levin ML, Williams J, Phair JP. Sporo-
trichosis: recurrent cutaneous, articular, and central nervous system
infection in a renal transplant recipient. Rev Infect Dis 1987; 9:369\u201375.
25. Gottlieb GS, Lesser CF, Holmes KK, Wald A. Disseminated sporotri-
chosis associated with treatment with immunosuppressants and tumor
necrosis factor\u2013a antagonists. Clin Infect Dis 2003; 37:838\u201340.
26. Rotz LD, Slater LN, Wack MF, Boyd AL, Scott EN, Greenfield RA.
Disseminated sporotrichosis with meningitis in a patient with AIDS.
Infect Dis Clin Prac 1996; 5:566\u20138.
27. Wroblewska M, Swoboda-Kopec E, Kawecki D, Sawicka-Grzelak A,
Stelmach E, Luczak M. Infection by a dimorphic fungus Sporothrix
schenckii in an immunocompromised patient. Infection 2005; 33:
28. Silva-Vergara ML, Maneira FR, De Oliveira RM, Santos CT, Etche-
behere RM, Adad SJ. Multifocal sporotrichosis with meningeal in-
volvement in a patient with AIDS. Med Mycol 2005; 43:187\u201390.
IDSA Guidelines for Management of Sporotrichosis \u2022 CID 2007:45 (15 November) \u2022 1265
29. Scott EN, Kaufman L, Brown AC, Muchmore HG. Serologic studies
in the diagnosis and management of meningitis due to Sporothrix
schenckii. N Engl J Med 1987; 317:935\u201340.
30. Field MJ, Lohr KN. Institute of Medicine Committee to Advise the
Public Health Service on Clinical Practice Guidelines. Clinical practice
guidelines: directions for a new program. Washington, DC: National
Academy Press, 1990:52\u201377.
31. Canadian Task Force on the Periodic Health Examination. The periodic
health examination. Can Med Assoc J 1979; 121:1193\u2013254.
32. Smego RA Jr, Castiglia M, Asperilla MO. Lymphocutaneous syndrome:
a review of non-sporothrix causes. Medicine (Baltimore) 1999; 78:
33. Hiruma M, Katoh T, Yamamoto I, Kagawa S. Local hyperthermia in
the treatment of sporotrichosis. Mykosen 1987; 30:315\u201321.
34. Hiruma M, Kawada A, Noguchi H, Ishibashi A, Conti Diaz IA. Hy-
perthermic treatment of sporotrichosis: experimental use of infrared
and far infrared rays. Mycoses 1992; 35:293\u20139.
35. Cabezas C, Bustamante B, Holgado W, Begue RE. Treatment of cu-
taneous sporotrichosis with one daily dose of potassium iodide. Pediatr
Infect Dis J 1996; 15:352\u20134.
36. Rex JH, Bennett JE. Administration of potassium iodide to normal
volunteers does not increase killing of Sporothrix schenckii by their
neutrophils or monocytes. J Med Vet Mycol 1990; 28:185\u20139.
37. Dismukes WE, Stamm AM, Graybill JR, et al. Treatment of systemic
mycoses with ketoconazole: emphasis on toxicity and clinical response
in 52 patients. National Institute of Allergy and Infectious Diseases
collaborative antifungal study. Ann Intern Med 1983; 98:13\u201320.
38. Calhoun DL, Waskin H, White MP, et al. Treatment of systemic spo-
rotrichosis with ketoconazole. Rev Infect Dis 1991; 13:47\u201351.
39. Restrepo A, Robledo J, Gomez I, Tabares AM, Gutierrez R. Itraconazole
therapy in lymphangitic and cutaneous sporotrichosis. Arch Dermatol
1986; 122:413\u20137.
40. Conti Diaz IA, Civila E, Gezuele E, et al. Treatment of human cutaneous
sporotrichosis with itraconazole. Mycoses 1992; 35:153\u20136.
41. Diaz M, Negroni R, Montero-Gei F, et al. A Pan-American 5-year study
of fluconazole therapy for deep mycoses in the immunocompetent
host. Pan-American Study Group. Clin Infect Dis 1992; 14(Suppl 1):
42. Winn RE, Anderson J, Piper J, Aronson NE, Pluss J. Systemic spo-
rotrichosis treated with itraconazole. Clin Infect Dis 1993; 17:210\u20137.
43. McGinnis MR, Nordoff N, Li RK, Pasarell L, Warnock DW. Sporothrix
schenckii sensitivity to voriconazole, itraconazole and amphotericin B.
Med Mycol 2001; 39:369\u201371.
44. Espinel-Ingroff A. Comparison of in vitro activities of the new triazole
SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366
against opportunistic filamentous and dimorphic fungi and yeasts. J
Clin Microbiol 1998; 36:2950\u20136.
45. Groll AH, Giri N, Petraitis V, et al. Comparative efficacy and distri-
bution of lipid formulations of amphotericin B in experimental Can-
dida albicans infection of the central nervous system. J Infect Dis
2000; 182:274\u201382.
46. Chapman SW, Pappas P, Kauffman C, et al. Comparative evaluation
of the efficacy and safety of two doses of terbinafine (500 and 1000
mg day(\ufffd1)) in the treatment of cutaneous or lymphocutaneous spo-
rotrichosis. Mycoses 2004; 47:62\u20138.
47. Hull PR, Vismer HF. Treatment of cutaneous sporotrichosis with ter-
binafine. Br J Dermatol 1992; 126(Suppl 39):51\u20135.
48. da Rosa AC, Scroferneker ML, Vettorato R, Gervini RL, Vettorato G,
Weber A. Epidemiology of sporotrichosis: a study of 304 cases in Brazil.
J Am Acad Dermatol 2005; 52:451\u20139.
49. Mahajan VK, Sharma NL, Sharma RC, Gupta ML, Garg G, Kanga AK.
Cutaneous sporotrichosis in Himachal Pradesh, India. Mycoses
2005; 48:25\u201331.
50. Itoh M, Okamoto S, Kariya H. Survey